ERIN FEITZ: Open Payments
NPI 1801078308 · ROELAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,710 in 207 payments from 19 companies in 2025. Trend: 2023 $2,778 · 2024 $2,815 · 2025 $25,710
Speaker / faculty: $18,675Food & beverage: $3,710Travel & lodging: $2,926Education: $399
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 67 | $23,798 |
| ABBVIE INC. | 48 | $404 |
| Biogen, Inc. | 16 | $377 |
| PFIZER INC. | 34 | $235 |
| Novartis Pharmaceuticals Corporation | 10 | $227 |
| Teva Pharmaceuticals USA, Inc. | 9 | $183 |
| Genentech USA, Inc. | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Lundbeck LLC | 2 | $56 |
| TG Therapeutics, Inc. | 2 | $43 |
Products named: Mavenclad, TYSABRI, KESIMPTA, QULIPTA, NURTEC ODT, UBRELVY, BOTOX, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
